vs
Beam Therapeutics Inc.（BEAM）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Beam Therapeutics Inc.的季度营收约是Repay Holdings Corp的1.5倍（$114.1M vs $78.6M），Beam Therapeutics Inc.净利率更高（214.1% vs -178.3%，领先392.4%），Beam Therapeutics Inc.同比增速更快（279.5% vs 0.4%），Repay Holdings Corp自由现金流更多（$23.2M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
BEAM vs RPAY — 直观对比
营收规模更大
BEAM
是对方的1.5倍
$78.6M
营收增速更快
BEAM
高出279.1%
0.4%
净利率更高
BEAM
高出392.4%
-178.3%
自由现金流更多
RPAY
多$110.3M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $78.6M |
| 净利润 | $244.3M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | -15.3% | -182.2% |
| 净利率 | 214.1% | -178.3% |
| 营收同比 | 279.5% | 0.4% |
| 净利润同比 | 370.4% | -3304.1% |
| 每股收益（稀释后） | $2.53 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMRPAY
| Q4 25 | $114.1M | $78.6M | ||
| Q3 25 | — | $77.7M | ||
| Q2 25 | — | $75.6M | ||
| Q1 25 | — | $77.3M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | — | $79.1M | ||
| Q2 24 | — | $74.9M | ||
| Q1 24 | — | $80.7M |
净利润BEAMRPAY
| Q4 25 | $244.3M | $-140.1M | ||
| Q3 25 | — | $-6.4M | ||
| Q2 25 | — | $-102.3M | ||
| Q1 25 | — | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $-5.2M |
毛利率BEAMRPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
营业利润率BEAMRPAY
| Q4 25 | -15.3% | -182.2% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | — | -138.7% | ||
| Q1 25 | — | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | -0.9% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -3.1% |
净利率BEAMRPAY
| Q4 25 | 214.1% | -178.3% | ||
| Q3 25 | — | -8.3% | ||
| Q2 25 | — | -135.2% | ||
| Q1 25 | — | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | -6.5% |
每股收益（稀释后）BEAMRPAY
| Q4 25 | $2.53 | $-1.68 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $1.2B | $484.4M |
| 总资产 | $1.5B | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资BEAMRPAY
| Q4 25 | $1.2B | $115.7M | ||
| Q3 25 | — | $95.7M | ||
| Q2 25 | — | $162.6M | ||
| Q1 25 | — | $165.5M | ||
| Q4 24 | — | $189.5M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $147.1M | ||
| Q1 24 | — | $128.3M |
总债务BEAMRPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益BEAMRPAY
| Q4 25 | $1.2B | $484.4M | ||
| Q3 25 | — | $616.9M | ||
| Q2 25 | — | $633.7M | ||
| Q1 25 | — | $755.7M | ||
| Q4 24 | — | $761.3M | ||
| Q3 24 | — | $754.7M | ||
| Q2 24 | — | $815.4M | ||
| Q1 24 | — | $813.8M |
总资产BEAMRPAY
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
负债/权益比BEAMRPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $23.2M |
| 自由现金流率自由现金流/营收 | -76.3% | 29.6% |
| 资本支出强度资本支出/营收 | 3.3% | 0.1% |
| 现金转化率经营现金流/净利润 | -0.34× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势，按日历期对齐
经营现金流BEAMRPAY
| Q4 25 | $-83.3M | $23.3M | ||
| Q3 25 | — | $32.2M | ||
| Q2 25 | — | $33.1M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | — | $60.1M | ||
| Q2 24 | — | $31.0M | ||
| Q1 24 | — | $24.8M |
自由现金流BEAMRPAY
| Q4 25 | $-87.0M | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率BEAMRPAY
| Q4 25 | -76.3% | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度BEAMRPAY
| Q4 25 | 3.3% | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率BEAMRPAY
| Q4 25 | -0.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
